Polynucleotides Rosacea Treatment in London

Results vary between individuals and depend on rosacea subtype, overall skin condition, lifestyle, and the number of sessions completed. Many patients who complete a course notice improvements in redness, texture, and quality persisting for several months. Maintenance polynucleotide injections are commonly recommended to sustain regenerative benefits. Realistic expectations based on individual concerns and the agreed plan are discussed thoroughly during your initial consultation.

Every treatment carries potential risks and individual considerations, and polynucleotide injection is no exception. Commonly reported side effects include temporary redness, localised swelling, or mild bruising at the injection site, which typically resolve within a short period. Less common reactions may include temporary sensitivity or minor irregularity at the injection site. Suitability is assessed individually during consultation, taking into account medical history, skin condition, and any prior procedures.

Most patients begin with a course of two to three sessions, spaced approximately two to four weeks apart, to allow cumulative regenerative activity to develop. For patients with a chronic skin condition such as rosacea, clinical assessment during consultation helps determine the appropriate session count and spacing. A personalised plan is confirmed following your initial face-to-face assessment.

Most patients describe the procedure as tolerable. Numbing cream is available and may be applied prior to the polynucleotide injection where comfort is a concern or the treatment area is particularly sensitive. Mild stinging or pressure may be noticed at the injection site during the session. Any discomfort typically resolves promptly. Your practitioner will adapt the approach throughout treatment to support comfort where needed.

Polynucleotide treatment is generally associated with minimal downtime. Some patients notice mild redness, slight swelling, or localised sensitivity in the treatment area for 24 to 48 hours following the session. These responses are typically transient and reflect normal tissue activity during the initial phase of skin regeneration. Detailed aftercare guidance is provided at the end of each session. Most patients are able to resume their usual activities within a short period following the procedure.

Polynucleotide treatment may be suitable for adults experiencing persistent facial redness, diffuse inflammation, uneven skin tone, or a compromised skin barrier associated with rosacea. It may also be considered for patients with concurrent concerns such as fine lines, crepey texture, or loss of skin elasticity. Suitability depends on overall health, rosacea subtype, and relevant medical history. Individuals who are pregnant, breastfeeding, or who present with certain health conditions may not be suitable at this time.

Initial improvements in skin hydration and a reduction in surface redness may become noticeable within the first two to four weeks following the first procedure. Progressive improvements in skin texture, barrier resilience, and tone generally develop over four to eight weeks as the treatment’s regenerative activity continues. The cumulative results of a complete course are often most apparent approximately eight to twelve weeks following the final session.

Polynucleotides treatment in London is frequently integrated into broader aesthetic medicine programmes alongside complementary treatments such as skin boosters, medical-grade skincare, or other injectable approaches, depending on clinical suitability. For patients with rosacea, timing and sequencing of any combined treatments are planned carefully to avoid aggravating reactive skin. Your practitioner will advise on the most appropriate approach for your individual skin concerns and goals during consultation.